Profusa

Profusa, Inc. is a medical technology company located in Emeryville, California. Founded in 2009, it specializes in developing biointegrated sensors that provide real-time, continuous monitoring of the body's chemistry. This innovative technology aims to enhance health and wellness by enabling personalized medicine through advanced biosensing. The company's flagship product, the Lumee™ Oxygen Platform, measures tissue oxygen levels in various body regions. It has received clinical approval in the European Union and is particularly beneficial for monitoring conditions such as peripheral artery disease and chronic wounds. Profusa's minimally invasive sensors deliver reliable, continuous data on physiological parameters, empowering healthcare providers and patients to manage health more effectively. Led by experienced professionals, including CEO Ben Hwang and Chief Scientific Officer Bill McMillan, Profusa targets healthcare providers and patients who need ongoing monitoring for chronic conditions. Their technology is designed to significantly impact disease management and improve health outcomes through accurate biosensing.

• Employees 2
• Founded 2009
• Annual Revenue $8250000
• Total Funding $79719122